Sales & Marketing News | pharmaphorum

News

Book explores why pharma’s digital sales shot has missed

The pharma industry has rapidly embraced digitalisation as a way to transform its sales engagement, but there has been little to show for the effort.

News

Illumina admits defeat in Grail quest, opting to divest

Illumina has said it will divest cancer detection company Grail, marking the end of a long-running antitrust dispute that has claimed the jobs of its former CEO and chair.

News

CHMP backs Biogen’s Skyclarys for Friedreich’s ataxia

Biogen’s Skyclarys is on course to becoming the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU after it was recommended

News

MSD claims 2nd FDA approval for Welireg, in kidney cancer

The FDA has approved MSD’s oral HIF-2 alpha inhibitor Welireg for a second cancer indication, relapsed or refractory advanced renal cell carcinoma (RCC), the most common f

News

White House says 48 drugs are heading for Medicare rebates

The Biden administration has generated a list of 48 drugs whose prices were raised faster than inflation in the last quarter of this year and may be subject to the mandato

News

SCOTUS will rule on abortion pill access in landmark case

The Supreme Court of the US has said it will consider a lower court ruling that would restrict access to the abortion pill mifepristone and is considered to be tied to the

Book explores why pharma’s digital sales shot has missed

Illumina admits defeat in Grail quest, opting to divest

CHMP backs Biogen’s Skyclarys for Friedreich’s ataxia

MSD claims 2nd FDA approval for Welireg, in kidney cancer

White House says 48 drugs are heading for Medicare rebates

SCOTUS will rule on abortion pill access in landmark case

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks